SEARCH

SEARCH BY CITATION

References

  • 1
    Turner R.A. (1965) Screening Methods in Pharmacology. New York: Academic Press; p. 152.
  • 2
    Paul A.I. (1996) Analgesic-antipyretic and anti-inflammatory agents and drugs employed in the treatment of gout. In: Peery B.M., Raymond W.R., editors. Goodman and Gilmans, The Pharmacological Basis of Therapeutic. New York: McGraw Hill; p. 6178.
  • 3
    Ashutoshkar (2003) Medicinal Chemistry, 2nd edn. New Delhi: New Age International Publishers; p. 329.
  • 4
    Andersen K., Launer L.J., Ott A., Hoes A.W., Breteler M.M.B., Hofman A. (1995) Do nonsteroidal anti-inflammatory drugs decrease the risk for Alzheimer’s Disease? The Rotterdam study. Neurology;45:14411445.
  • 5
    Breitner J.C.S. (1996) The role of anti-inflammatory drugs in the prevention and treatment of Alzheimer’s Disease. Annu Rev Med;47:401411.
  • 6
    Sveigard H.H., Dalgaard L. (2000) Evaluation of blood-brain barrier passage of a Muscarine M1 agonist and a series of analogous tetrahydropyridines measured by in vivo microdialysis. Pharm Res;17:7076.
  • 7
    Ma Y., Loesewetter D.O., Kagpda E.M., Huang B.X., Eckelman W.C. (2002) Identification of metabolites of fluorine-18-labelled M2 Muscarinic receptor agonist, 3-(3[(3-fluoropropyl)thio]-1,2,5-thiadiazol-4-yl)-1,2,5,6-tetrahydro-1-methylpyridine, produced by human and rat hepatocytes. J Chromatogr B;766:319329.
  • 8
    Tsai P.L., Wang J.P., Chang C.W., Kuo S.C., Lee Chao P.D. (1998) Constituents and bioactive principles of Polygonum chinensis. Phytochemistry;49:16631666.
  • 9
    Isshiki K., Asai Y., Tanaka S., Nishio M., Uchida T., Okuda T., Kamatsubara S., Sakurai N. (2001) Aurantiamide acetate, a selective cathepsin inhibitor, produced by Aspergillus penicilloides. Biosci Biotechnol Biochem;65:11951197.
  • 10
    Ferreira E.O., Salvador M.J., Pral E.M., Alfieri S.C., Ito I.Y., Dias D.A. (2004) A new heptasubstituted (E)-aurone glucoside and other aromatic compounds of Gomphrena agrestis with biological activity. Z Naturforsch C;59:499505.
  • 11
    Ng T.B., Liu Y., Cheng C.H.K., Wang Z. (2003) Antioxidant activity of compounds from the medicinal herb Aster tataricus. Comp Biochem Physiol C: Toxicol Pharmacol;136:109115.
  • 12
    Yen C.T., Hwang T.L., Wu Y.C., Hsieh P.W. (2009) Design and synthesis of new N-(Fluorenyl-9-methoxycarbonyl) (Fmoc)-dipeptides as anti-inflammatory agents. Eur J Med Chem;44:19331940.
  • 13
    Burch R.M., Weitzberg M., Blok N., Muhlhauser R., Martin D., Farmer S.G., Bator J.M., Connor J.R., Green M., Ko C., Kuhn W., McMillan B.A., Raynor M., Shearer B.G., Tiffany C. (1991) N-(Fluorenyl-9-methoxycarbonyl) amino acids, a class of antiinflammatory agents with a different mechanism of action. Proc Natl Acad Sci USA;88:355359.
  • 14
    Hamilton G.S., Mewshaw R.E., Bryant C.M., Feng Y., Endemann G., Madden K.S., Janczak J.E., Perumattam J., Stanton L.W., Yang X. (1995) Fluorenylalkanoic and benzoic acids as novel inhibitors of cell adhesion processes in leukocytes. J Med Chem;38:16501656.
  • 15
    Jan C.R., Wang J.L., Chou K.J., Cheng J.S., Lee K.C., Tseng L.L., Wang S.P., Tang K.Y., Huang J.K. (2000) NPC-14686, a novel anti-inflammatory agent, increased intracellular Ca2+ concentrations in MDCK renal tubular cells. Int J Immunopharmacol;22:915921.
  • 16
    Sandberg L.B., Leslie J.G., Leach C.T., Torres V.L., Smith A.R., Smith D.W. (1985) Calculations of electrostatic interactions in biological systems and in solutions. Pathol Biol;33:266275.
  • 17
    Yeh H., Ornstein-Goldstein N., Indik Z., Sheppard P., Anderson N., Rosenbloom J.C., Cicila G., Yoon K., Rosenbloom J. (1987) Sequence variation of bovine elastin mRNA due to alternative splicing. Coll Relat Res;7:235247.
  • 18
    Sandberg L.B., Soskel N.T., Leslie J.B. (1981) Elastin structure, biosynthesis, and relation to disease states. Engl J Med;304:566579.
  • 19
    Indik Z., Yeh H., Ornstein-Goldstein N., Sheppard P., Anderson N., Rosenbloom J., Peltnen L., Rosenbloom J. (1987) Alternative splicing of human elastin mRNA indicated by sequence analysis of cloned genomic and complementary DNA. Proc Natl Acad Sci USA;84:56805684.
  • 20
    Gowda D.C., Parker T.M., Harris R.D., Urry D.W. (1994) Synthesis, characterizations, and medical applications of bioelastic materials. In: Basava C., Ananthramaiah G.M., editors. Peptides. Boston: Birkhauser; p. 81111.
  • 21
    Urry D.W., Nicol A., Gowda D.C., Hoban L.D., Mckee A., Williams T., Olsen D.B., Cox B.A. (1993) Medical application of bioelastic materials. In: Gebelein C.G., editor. Biotechnological Polymers: Medical, Pharmaceutical and Industrial Applications. Atlanta, GA: Technomic Publishing; p. 82103.
  • 22
    Urry D.W., McPherson D.T., Xu J., Daniell H., Guda C., Gowda D.C., Jing N., Parker T.M. (1996) Protein-based polymeric materials (Synthesis and properties). In: Salamone J.C., editor. Polymeric Materials Encyclopedia. Boca Raton, FL: CRC Press; p. 72637279.
  • 23
    Shivakumara K.N., Prakasha K.C., Suresha G.P., Suhas R., Gowda D.C. (2007) Synthesis and antimicrobial study of amino acids conjugated benzylpiperazine derivatives. mySCIENCE;II:100106.
  • 24
    Suresha G.P., Prakasha K.C., Shivakumara K.N., Kapfo W., Gowda D.C. (2009) Design and synthesis of heterocyclic conjugated peptides as novel antimicrobial agents. Int J Pept Res Ther;15:2530.
  • 25
    Suhas R., Chandrashekar S., Gowda D.C. (2011) Synthesis of elastin based peptides conjugated to benzisoxazole as a new class of potent antimicrobials – a novel approach to enhance biocompatibility. Eur J Med Chem;46:704711.
  • 26
    Suresha G.P., Suhas R., Kapfo W., Gowda D.C. (2011) Urea/thiourea derivatives of quinazolinone-lysine conjugates: synthesis and structure-activity relationships of a new series of antimicrobials. Eur J Med Chem;46:25302540.
  • 27
    Suhas R., Chandrashekar S., Gowda D.C. (2011) A new family of highly potent inhibitors of microbes: synthesis and conjugation of elastin based peptides to piperazine derivative. Int J Pept Res Ther; DOI: 10.1007/s10989-011-9282-8.
  • 28
    Anwer M.K., Spatola A.F. (1980) An advantageous method for the rapid removal of hydrogenolysable protecting groups under ambient conditions: synthesis of leucine-enkephalin. Synthesis;11:929932.
  • 29
    Gowda D.C., Gowda B.K.K., Rangappa K.S. (2001) Sequence dependence of oxidation of some repeating pentapeptide sequences of elastin with electrolytically generated Mn(III): synthesis, kinetics and mechanistic study. J Phys Org Chem;14:716724.
  • 30
    Quagliato D.A., Andrae P.M., Matelan E.M. (2000) Efficient procedure for the reduction of α-amino acids to enantiomerically pure α-methylamines. J Org Chem;65:50375042.
  • 31
    Vogel G.H., Vogel W.H. (1998) Drug Discovery and Evaluation. Berlin: Springer Verlag, p. 413.
  • 32
    Ghosh M.N. (1984) Fundamentals of Experimental Pharmacology, 2nd edn. Calcutta: Scientific Book Agency, p. 145.
  • 33
    Winter C.A., Risley E.A., Nuss G.W. (1962) Carrageenan-induced oedema in hind paw of the rat as an assay for anti-inflammatory drugs. Proc Soc Exp Biol Med;111:544547.
  • 34
    Kulkarni S.K. (1999) Hand Book of Experimental Pharmacology, 3rd edn. New Delhi: Vallabh Prakashan, p. 149.
  • 35
    Djahanjuiri B. (1969) Effect of a single dose of phentolamine and mj 1999 on aspirin-induced gastric ulceration in rats. J Pharma Pharmacol;21:341345.